ArticleAddiction biology2026
Associations Between Vitamin D Status and Clinical Presentation Among French Inpatients With Substance Use Disorders.
Article in Addiction biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Associations Between Vitamin D Status and Clinical Presentation Among French Inpatients With Substance Use Disorders.Addiction biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNumerous studies have demonstrated that vitamin D plays a crucial role in modulating dopaminergic pathways, suggesting a potential role in the pathophysiology of addictive disorders. However, among individuals with substance use disorders (SUDs), the link between vitamin D and addiction-related symptoms has not been sufficiently studied.
objectiveThis study aims to explore among inpatients treated for various types of SUDs differences in addiction-related, psychopathological and biological characteristics based on vitamin D status.
methodsThe sample included 260 participants hospitalized in a French addiction treatment unit. Vitamin D concentration and other biomarkers, SUDs severity and other psychiatric disorders, cognitive functioning and impulsivity were collected at hospital admission (T0). Perceived negative affectivity and craving (for the main substance and food) were collected at T0 and hospital discharge (T1).
resultsAbout 89.3% of the participants had a vitamin D deficiency as defined by French recommendations (< 30 ng/mL). Using univariate between-group analyses, vitamin D deficiency was associated with higher body weight and lower calcium plasma levels at T0, as well as increased craving intensity for both the substance at the origin of the treatment and food at T1. Multivariate regression analyses showed no significant associations between vitamin D or calcium levels and craving intensities at T1.
conclusionThis study confirms the high prevalence of vitamin D deficiency among inpatients treated for SUDs. Although preliminary, our findings highlight the importance of assessing vitamin D levels in SUDs. They call for further research on its role in relapse vulnerability and the potential benefits of its supplementation during drug withdrawal treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.